National Comprehensive Cancer Network



About NCCN

Esophageal/Gastric Cancers Panel - Disclosures as of 10/31/2011

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict

Jaffer A. Ajani, MD

Bayer HealthCare;
ImClone Systems Incorporated;
Ascenta;
Genta;
sanofi-aventis U.S.;
Taiho Parmaceuticals Co., Ltd.

Bristol-Myers Squibb Company;
sanofi-aventis U.S.

None

None

None

James S. Barthel, MD

None

None

None

Merit Medical Endotek

None

David J. Bentrem, MD, MS

None

None

None

None

None

Thomas A. D'Amico, MD

None

Scanlan

None

None

None

Prajnan Das, MD, MS, MPH

None

None

None

None

None

Crystal S. Denlinger, MD, FACP

None

Vicus Pharmaceuticals

None

None

None

Charles S. Fuchs, MD, MPH

None

Amgen Inc.;
AstraZeneca Pharmaceuticals LP;
Bristol-Myers Squibb Company;
Genentech, Inc.;
Genomic Health, Inc.;
GlaxoSmithKline;
ImClone Systems Incorporated;
Merck & Co., Inc.;
Alnylam;
mersana;
Roche Laboratories, Inc.

None

None

None

Lauren Gallagher, RPh, PhD

None

None

None

None

None

Hans Gerdes, MD

None

None

None

None

None

Robert E. Glasgow, MD

None

None

None

None

None

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

James A. Hayman, MD, MBA

None

None

None

None

None

Wayne L. Hofstetter, MD

None

None

None

None

None

David H. Ilson, MD, PhD

None

None

None

None

None

Rajesh N. Keswani, MD

None

None

None

None

None

Lawrence R. Kleinberg, MD

None

None

None

None

None

W. Michael Korn, MD

None

Celgene Corporation;
Daiichi- Sankyo Co.

None

None

None

A. Craig Lockhart, MD, MHS

None

None

None

None

None

Joan S. McClure, MS

None

None

None

None

None

Nicole McMillian, MS

None

None

None

None

None

Mary F. Mulcahy, MD

None

None

None

None

None

Mark B. Orringer, MD

None

None

None

None

None

Raymond U. Osarogiagbon, MD, FACP

Bristol-Myers Squibb Company;
Eli Lilly and Company

Genentech, Inc.;
Genentech, Inc.;
OSI Pharmaceuticals, Inc.

None

None

None

James A. Posey, MD

None

None

None

None

None

Aaron R. Sasson, MD

None

None

None

None

None

Walter J. Scott, MD, FACS

None

None

None

Johnson & Johnson

None

Vivian E. Strong, MD

None

None

None

None

None

Hema Sundar, PhD

None

None

None

None

Cephalon, Inc.

Thomas K. Varghese, MD

None

None

None

None

None

Graham Warren, MD, PhD

None

None

None

None

None

Mary Kay Washington, MD, PhD

None

Genentech, Inc.

None

None

None

Christopher G. Willett, MD

None

None

None

None

None

Cameron D. Wright, MD

None

None

None

None

None